insights_auto
Why is NTRA up 2.76%?
Dive Deeperchevron_right
NTRA:BCBA
Natera Cedear
ARS 12,640.00
arrow_upward
+2.76%(+340.00) 1D
Oct 9, 5:00:00 PM GMT-3 · ARS
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NTRA...
Open
ARS 12,500.00
High
ARS 12,780.00
Low
ARS 12,500.00
Mkt. cap
57.76B
Avg. vol.
0.00
Volume
933.00
52-wk high
ARS 13,680.00
52-wk low
ARS 9,900.00
No. of employees
6K
Open
ARS 12,500.00
High
ARS 12,780.00
Low
ARS 12,500.00
Mkt. cap
57.76B
Avg. vol.
0.00
Volume
933.00
52-wk high
ARS 13,680.00
52-wk low
ARS 9,900.00
No. of employees
6K
News stories
From web sources and news partners
Investing.com Nigeria
·
12 hours ago
Form 4 Natera Inc For: 10 October By Investing.com
Yahoo Finance
·
21 hours ago
Natera (NTRA) Stock May Be 33% Below Fair Value Despite FDA Breakthrough News
StockStory
·
1 day ago
Why Natera (NTRA) Stock Is Up Today
Investing.com
·
1 day ago
Natera receives FDA breakthrough designation for cancer test
Profile
Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA testing technology, with a focus on women's health, cancer, and organ health. Natera's proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments in San Carlos, California and Austin, Texas. Wikipedia
About Natera Cedear
CEOSteven Chapman
Employees6.14K
FoundedJan 1, 2004
HeadquartersAustin, Texas, United States
SectorBiotechnology
Websitenatera.com